Biokobi international, UAB - financials and debts

Company age: 10 y. 3 mo.

Update

Biokobi international - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 172,345 368,639 500,577 820,528 1,102,205 1,091,549 837,835 728,289
Profit before tax -10,935 10,338 4,787 8,657 18,777 11,857 9,985 11,521
Net profit -10,935 9,801 3,991 7,362 15,914 9,875 8,453 9,764
Equity -8,737 1,554 73,045 80,407 96,321 106,196 114,649 124,412
Liabilities 84,499 119,586 118,919 115,363 136,555 112,250 96,773 84,423
Non-current assets 0 0 2,052 1,342 2,401 24,992 27,677 53,569
Current assets 75,662 121,040 189,902 194,753 224,229 192,628 183,745 155,266
Total assets 75,662 121,040 191,954 196,095 226,630 217,620 211,422 208,835
Taxes paid
STI taxes - - - - - 107,878 67,131 39,990
Social insurance contributions - - - - - 37,133 18,941 5,399
Financial indicators
Revenue change y/y - +113.9% +35.8% +63.9% +34.3% -1.0% -23.2% -13.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -14.5% 8.1% 2.1% 3.8% 7.0% 4.5% 4.0% 4.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - 630.7% 5.5% 9.2% 16.5% 9.3% 7.4% 7.8%
Profit margin Net profit margin. Shows the overall profitability of the company. -6.3% 2.7% 0.8% 0.9% 1.4% 0.9% 1.0% 1.3%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -6.3% 2.8% 1.0% 1.1% 1.7% 1.1% 1.2% 1.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 77.0 1.6 1.4 1.4 1.1 0.8 0.7
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 62,044 122,880 136,520 149,187 130,955 147,174 167,567 171,362

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Biokobi international - Social security debts

From To Debt, €
2026-05-17 2026-05-17 1090.11
2024-04-16 2024-04-18 3106.14
2023-05-02 2023-05-04 2.04
2023-04-25 2023-04-28 2.04
2023-03-17 2023-03-23 9.50
2023-03-16 2023-03-16 0.49
2023-02-17 2023-02-21 104.95
2022-08-23 2022-09-12 0.90
2022-07-25 2022-08-15 0.36
2022-05-18 2022-05-18 0.03
2022-05-17 2022-05-17 2215.44
2022-04-25 2022-05-16 0.03
2022-03-16 2022-03-17 30.92

Biokobi international - VMI tax arrears

From To Overdue, €
2024-12-30 2024-12-30 177.94
2024-12-18 2024-12-27 0.07
2024-11-28 2024-12-17 0.08

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Biokobi international, UAB (code 304285464) is a Private Limited Liability Company operating in intermediation service activities for specialised retail sale. In the latest financial year, 2025, the company generated revenue of €728.3K and net profit of €9.8K, with a profit margin of 1.3%. Revenue declined by 13.1% year on year and by 33.3% over two years, falling from €1.09M in 2023 to €837.8K in 2024 and then to €728.3K in 2025. Despite the lower turnover, net profit stayed broadly stable at €9.9K in 2023, €8.5K in 2024 and €9.8K in 2025. At the end of 2025, total assets stood at €208.8K, equity at €124.4K and liabilities at €84.4K, giving an equity ratio of 59.6% and debt-to-equity of 0.68. Return on equity was 7.8% and return on assets 4.7%. Asset turnover reached 3.49x. With revenue per employee of €182.1K and profit per employee of €2.4K, the company showed solid operating efficiency relative to its size.